Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): What has changed over the time? Preliminary results of the VICTOR-6 study.

Marina Elena Cazzaniga, Virginia Casadei, Luigi Cavanna et al.|Journal of Clinical Oncology|2017

Cited by 2